Superficial non-ampullary duodenal epithelial tumors now: endoscopic diagnosis and therapy

Author:

Hirose Takashi1ORCID,Kato Motohiko2,Hatta Waku3,Abe Seiichiro4ORCID,Takizawa Kohei5,Yano Tomonori6

Affiliation:

1. Nagoya University Graduate School of Medicine Department of Gastroenterology and Hepatology, , Nagoya 466-8550 , Japan

2. Keio University Graduate School of Medicine Department of Gastroenterology and Hepatology, , Tokyo , Japan

3. Tohoku University Graduate School of Medicine Department of Gastroenterology and Hepatology, , Sendai , Japan

4. National Cancer Center Hospital Endoscopy Division, , Tokyo , Japan

5. Koyukai Shin-Sapporo Hospital Department of Endoscopy, , Hokkaido , Japan

6. National Cancer Center Hospital East Department of Gastroenterology and Endoscopy, , Chiba , Japan

Abstract

Abstract With the recent increase in the frequency of duodenal tumor detection, significant progress has been made in endoscopic diagnosis and treatment. Although the first guidelines were issued in Japan, patient treatment varies widely among institutions. There is a need for improving the quality of endoscopic diagnosis and more curative and safer treatments. Biopsy is the standard diagnostic method; however, the diagnostic accuracy of endoscopic biopsy is not so high. Therefore, the differentiation of superficial non-ampullary duodenal epithelial tumors from non-neoplastic lesions is being developed. The incidence of lymph node and distant metastases of duodenal epithelial tumors is extremely rare in intramucosal carcinomas, and they are considered good candidates for endoscopic treatment if the technical difficulties can be resolved. Adverse events associated with endoscopic treatment are greatly reduced at advanced facilities through novel resection and closure methods, and further improvements are expected in the future. Clarifying the risk of metastatic recurrence may lead to the development of more appropriate treatments and curative resection criteria.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Message from the Editor-in-Chief;Japanese Journal of Clinical Oncology;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3